Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors

Part of paid clinical trials in Fort Sam Houston, Texas.

Sponsor
San Antonio Cancer Institute
Study ID
NCT00003711
Phase
PHASE1
Status
Completed

Conditions

  • Unspecified Adult Solid Tumor, Protocol Specific

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy with pemetrexed disodium and irinotecan in treating patients who have metastatic solid tumors.

Key Dates

Start date
Sep 30, 1997
Status verified
Apr 2000
Completion
Sep 30, 2004

Study Design

Primary purpose
TREATMENT

Locations (2)

FacilityCityStateZIPSite coordinators
Brooke Army Medical CenterFort Sam HoustonTexas78234-
San Antonio Cancer InstituteSan AntonioTexas78229-

Find similar trials in Fort Sam Houston, TX

By research site
Brooke Army Medical Center· Fort Sam Houston, TXSan Antonio Cancer Institute· San Antonio, TX

Related Studies